Showing results (351-360 of 434) with videos related to

Sort By:
Pageof 44
Bone|May 9, 2002
Three-dimensional cultures of normal human osteoblasts: proliferation and differentiation potential in vitro and upon ectopic implantation in nude miceD Ferrera, S Poggi, C Biassoni, et al.
Stem Cells (Dayton, Ohio)|October 10, 2013
Membrane biophysics define neuron and astrocyte progenitors in the neural lineageJ L Nourse, J L Prieto, A R Dickson, et al.
Health Technology Assessment (Winchester, England)|November 5, 2010
Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancerJ Greenhalgh, C McLeod, A Bagust, et al.
Hepato-Gastroenterology|May 1, 1997
Primary biliary cirrhosis: Dutch application of the Mayo Model before and after orthotopic liver transplantationG M van Dam, B W Verbaan, T M Therneau, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1994
Systemic and renal effects of nifedipine in cyclosporine-associated hypertensionS C Textor, L Schwartz, D J Wilson, et al.
International Archives of Allergy and Immunology|January 1, 1992
Comparative immunoreactive profiles of Japanese and American patients with primary biliary cirrhosis against mitochondrial autoantigensT Iwayama, P S Leung, M Rowley, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitisW R Kim, J J Poterucha, R H Wiesner, et al.
Hepatology (Baltimore, Md.)|November 1, 1992
M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena?P A Davis, P Leung, M Manns, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancerS Wojtowicz-Praga, J Torri, M Johnson, et al.
Health Technology Assessment (Winchester, England)|July 27, 2013
Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluationT Brown, G Pilkington, A Bagust, et al.
Pageof 44